Safety Profile, Tolerability, and Who Should Consider Retatrutide Retatrutide's most common adverse events are gastrointestinal: nausea, vomiting, and constipation, typically mild to moderate and dose-dependent
Both classes share the same primary side effects (nausea, occasional vomiting, constipation, reflux, fatigue in the early weeks)
Anthem denied coverage, citing a vague and amorphous rule that does not permit use of any drug mainly used for weight loss. But the plan documentation, consisting of less than 9 pages in total, was virtually non-existent and utterly failed to properly address and define the use and management of Zepbound
Relevant peptides: The CJC-1295 and Ipamorelin combination represents the most common GH-releasing stack